|
2024
|
P/S
|
Pharmaceutical preparations for use in treating cancer, namely, lymphoma and leukemia; pharmaceut... |
|
|
Invention
|
Modified immune effector cells. The present application provides compositions and methods of use ... |
|
|
Invention
|
Methods for manufacturing car t cells. The present disclosure relates generally to methods of mak... |
|
|
Invention
|
Anti-cd22 chimeric antigen receptor (car) therapies. Provided herein are compositions and methods... |
|
|
Invention
|
Compositions and methods for immunotherapies. Disclosed herein is a composition comprising one or... |
|
|
Invention
|
Compositions and methods for immunotherapies. The present application provides recombinant polype... |
|
2023
|
Invention
|
Multiplex cell selection compositions and uses thereof. Multiplex cell selection compositions and... |
|
|
Invention
|
Compositions and methods for allogeneic immunotherapies. The present application provides composi... |
|
|
Invention
|
Compositions and methods for improved immunotherapies. The present application provides recombina... |
|
|
Invention
|
Split receptor switch polypeptides and uses thereof. What is disclosed herein is a split receptor... |
|
|
Invention
|
Cd2 recruiting chimeric antigen receptors and fusion proteins. The present application provides e... |
|
|
Invention
|
Cytokine receptor switch polypeptides and uses thereof. Disclosed herein is a cytokine receptor s... |
